CNTA — Centessa Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapNeutral

Annual balance sheet for Centessa Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	595	394	257	482	295
Net Total Receivables	16.8	26.7	39.1	45.3	60.3
Prepaid Expenses
Total Other Current Assets
Total Current Assets	629	438	315	536	368
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.162	1.17	13	11.8	10.9
Long Term Investments
Other Long Term Assets
Total Assets	630	444	360	577	687
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	24.6	38.3	39.4	58	42.9
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	138	108	124	175	161
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	492	336	236	402	527
Total Liabilities & Shareholders' Equity	630	444	360	577	687
Total Common Shares Outstanding